Ergomed bolsters post-marketing biz through acquisition

By Dan Stanton

- Last updated on GMT

Ergomed bolsters post-marketing biz through acquisition

Related tags Pharmacology

UK-based CRO Ergomed has acquired medical information firm Sound Opinion as a boost to its post-marketing services.

The deal announced this morning will see contract research organisation (CRO) Ergomed add Sound Opinion to its post-marketing business, PrimeVigilance, acquired in July 2014.

Ergomed’s CEO Miroslav Reljanovic described the deal as fitting in with the firm’s strategy to expand its post-marketing services capacity, “a sector we think is critical to the future approval of new medicines and treatments.”

Neil Clark, Chief Financial Officer of the firm told Outsourcing-Pharma that “Ergomed’s medium term strategy is to build out the combined strength in UK medical information services into the main European markets whilst continuing to expand in the UK providing medical information services to Sound Opinion clients.”

Sound Opinion is a virtual business, and thus there are no issues with regards to transfering property or staff, we were told. The current operational staff and management of Sound Opinion will all stay involved with the business after completion.

Post-marketing services

The post-marketing sector is a growing area for CROs, according to Ergomed, and such services help drug companies support their products in the marketplace.

“This can include safety services such as pharmacovigilance and product information services for doctors, patients and pharmacists,”​ Clark explained.

“In addition there are other late stage clinical trials that are run post–approval and also advice is often taken with regards to strategy on pricing and reimbursement, epidemiology and also regulatory strategies to ensure a drug is correctly positioned in the market.”

However, Ergomed is not the only company operating in this sector: “There is competition from other CROs and service providers,” ​Clark said. “Pharma companies can also do this all in–house but increasingly they are out sourcing some or all of these services.”

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers